Navigation Links
DanDrit Biotech USA, Inc. Signs Placement Agency Agreement with Sunrise Securities Corp. and Form S-1 Registration Statement Becomes Effective
Date:8/14/2014

All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports.  Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements.

Contact:

Wolfe Axelrod Weinberger Associates, LLC
Stephen D. Axelrod, CFA/Donald C. Weinberger
(212) 370-4500, (212) 370-4505 fax
steve@wolfeaxelrod.com, don@wolfeaxelrod.com

 

 


'/>"/>
SOURCE DanDrit Biotech USA, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  U.S. biotech company ... an exclusive license for technology developed by the ... expression in plants, including for applications in production of ... The technology was developed under the direction of ... Kultevat and former president of the Danforth Plant Science ...
(Date:9/18/2014)... SEATTLE , Sept. 18, 2014 /PRNewswire/ - Oncothyreon ... pricing of previously announced concurrent but separate underwritten offerings ... price to the public of $2.00 per share, for ... of its Series A Convertible Preferred Stock at a ... expected gross proceeds of $20 million. Each share of ...
(Date:9/18/2014)... 2014 OMICS Group International invites ... participate in the ‘Open Access Week’ by actively ... OMICS Group Pharma Journals from 20-26th October, ... fastest emerging Sciences, accelerating with a tremendous speed ... the globe. The industry is gearing with innovation ...
(Date:9/18/2014)... pretty expensive. Now a team led by an engineer ... of designs that will let scientists slash the cost ... pump. , Syringe pumps are used to dispatch precise ... chemicals in a reaction. They can also cost hundreds ... his team of Michigan Tech students published the library ...
Breaking Biology Technology:Kultevat obtains license of gene switch technology 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3Doing science just got cheaper -- and faster 2
... Inc. , a biotechnology company focused on the development ... diseases, has entered into an in-vitro diagnostics patent license ... firm. , ,Under the agreement, which will be effective ... enzymes in its products. Prodesse also receives the authority ...
... Allis, Wis. - After conducting a lengthy financial ... Healthcare has announced the resignations of three executives, ... errors in its financial statements. , ,The stock market ... as the value of Merge shares declined by 41 ...
... - The relocation of one area biotech has resulted in ... take it even higher. , ,And while GWC Technologies ... interactions on bioarrays, is not yet in the penthouse, the ... high-tech product development, according to president and CEO Tim Burland. ...
Cached Biology Technology:Merge execs step down following investigation 2Merge execs step down following investigation 3Madison biotech continues its climb 2Madison biotech continues its climb 3Madison biotech continues its climb 4
(Date:9/18/2014)... The ability to acquire and creatively manipulate spoken language ... over the past 6 million years of human evolution ... is the best candidate gene we now have," says ... LMU. In his efforts to understand the molecular biological ... step forward. The results of his latest study, undertaken ...
(Date:9/18/2014)... stored in DNA, tiny strands of nucleic acid that ... express this genetic data, our DNA is copied into ... that perform tasks in our cells. , Several ... molecule. Unlike all other known RNAs, this molecule is ... are abundant, little has been known about how they ...
(Date:9/18/2014)... colleagues have built the first smartphone app that ... behavioral trends. In other words, your smartphone knows ... don,t -- and how that affects you. , ... depression and loneliness to their academic performance, also ... for example, to monitor mental health, trigger intervention ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4
... Forest Service scientists have found that prescribed fires with the ... oak ecosystems. Forest Service researchers are helping land ... oak regeneration from acorns is a concern. "Acorns ... the most part protected from fire," says Cathryn Greenberg, Forest ...
... in JoVE , the Journal of Visualized ... spider silk from bacteria. The procedure presented in the ... standardizing a key step known as "post-spin." In this ... to increase fiber strength. These mechanical improvements produce uniform ...
... Waterlogged protein . . . Proteins, biological ... our bodies, are known to rely heavily on the ... remained unclear. In a paper published in Physical Review ... new evidence that suggests water is even more involved ...
Cached Biology News:Leaf litter and soil protect acorns from prescribed fire 2The future of biomaterial manufacturing: Spider silk production from bacteria 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2012 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2012 3
...
... detector for ambient HPLC. Contains connections ... for two external devices such as ... an analog output from the 90 ... recorders. Includes an input for synchronization ...
...
...
Biology Products: